A Budget Impact Analysis (Bia) Of The Use Of Paricalcitol For The Treatment Of Secondary Hyperparathyroidism (Shpt) In End Stage Renal Disease Patients
Value Health
.
2014 Nov;17(7):A467.
doi: 10.1016/j.jval.2014.08.1313.
Epub 2014 Oct 26.
Authors
V Lorenzoni
1
,
F Pierotti
1
,
G Turchetti
1
Affiliation
1
Scuola Superiore Sant'Anna, Pisa, Italy.
PMID:
27201327
DOI:
10.1016/j.jval.2014.08.1313
No abstract available